2seventy bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch 2seventy bio and buy or sell other stocks, ETFs, and their options commission-free!About TSVT
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer.
CEOChip Baird, III, MBA
CEOChip Baird, III, MBA
Employees65
Employees65
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2021
Founded2021
Employees65
Employees65
TSVT Key Statistics
Market cap262.33M
Market cap262.33M
Price-Earnings ratio-49.12
Price-Earnings ratio-49.12
Dividend yield—
Dividend yield—
Average volume150.58K
Average volume150.58K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.30
52 Week high$5.30
52 Week low$2.29
52 Week low$2.29
Stock Snapshot
2seventy bio(TSVT) stock is priced at $5.00, giving the company a market capitalization of 262.33M. It carries a P/E multiple of -49.12.
On 2025-12-14, 2seventy bio(TSVT) stock opened at —, reached a high of —, and a low of —.
The 2seventy bio(TSVT)'s current trading volume is 0, compared to an average daily volume of 150.58K.
In the last year, 2seventy bio(TSVT) shares hit a 52-week high of $5.30 and a 52-week low of $2.29.
In the last year, 2seventy bio(TSVT) shares hit a 52-week high of $5.30 and a 52-week low of $2.29.
People also own
Based on the portfolios of people who own TSVT. This list is generated using Robinhood data, and it’s not a recommendation.